News Roche Holding AG Berne S.E.

Equities

RO

CH0012032113

Real-time Estimate Cboe Europe Other stock markets 11:20:00 2024-06-07 EDT			5-day change	1st Jan Change
266.4 ^CHF	+12.23%		-0.47%	-8.62%

05:14pm	Roche: efficacy of Evrysdi in spinal muscular atrophy	CF
05:12pm	Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Roche: efficacy of Evrysdi in spinal muscular atrophy	11:14am	CF
Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	11:12am	MT
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk	10:41am	BU
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	12:43am	MT
AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	06-06	MT
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06-06	DJ
The odds of rates getting cut in 2024 may be better than you think	06-05
ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating	06-03	ZD
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	06-03	ZD
Astra's Enhertu breast cancer trial shows 'unprecedented' results	06-02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	06-02	RE
ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	05-31	ZD
Transcript : Roche Holding AG - Shareholder/Analyst Call	05-31
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	05-30	ZD
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	05-29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	05-29
European Midday Briefing : Mood Sours as Fed Rate-Cut Bets Curtailed	05-29	DJ
Roche: FDA grants priority review in breast cancer	05-29	CF
Roche's Metastatic Breast Cancer Treatment Granted Priority Review by US FDA	05-29	MT
Roche Breast-Cancer Drug Gets Priority Review in the U.S.	05-29	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am